Apogee Therapeutics shares owned by Paradigm Biocapital Advisors
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Paradigm Biocapital Advisors
from 13F filings
Historical chart of Paradigm Biocapital Advisors investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Paradigm Biocapital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $61M | 1.5M | 39.73 |
| 2025-06-30 | $42M | 959k | 43.43 |
| 2025-03-31 | $36M | 962k | 37.36 |
| 2024-12-31 | $58M | 1.3M | 45.30 |
| 2024-09-30 | $41M | 702k | 58.74 |
| 2024-06-30 | $13M | 330k | 39.35 |
| 2024-03-31 | $22M | 330k | 66.45 |
More positions owned by Paradigm Biocapital Advisors
View all positions for Paradigm Biocapital Advisors